Refine my results

Phase III study of ACVBP versus ACVBP plus rituximab for patients with localized low-risk diffuse large B-cell lymphoma (LNH03-1B)

Ketterer, N. ; Coiffier, B. ; Thieblemont, C. ; Fermé, C. ; Brière, J. ; Casasnovas, O. ; Bologna, S. ; Christian, B. ; Connerotte, T. ; Récher, C. ; Bordessoule, D. ; Fruchart, C. ; Delarue, R. ; Bonnet, C. ; Morschhauser, F. ; Anglaret, B. ; Soussain, C. ; Fabiani, B. ; Tilly, H. ; Haioun, C.

In: Annals of Oncology, 2013, vol. 24, no. 4, p. 1032-1037